Search
for
Sort by
Research 361–390 of 1000+
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Cell death in skin function, inflammation, and disease
- Adverse Reactions to Biologic Medications Used in Allergy and Immunology Diseases
- Off-label dermatologic uses of IL-23 inhibitors
- Stem-cell therapy in dermatology – Challenges and opportunities
- Cytoprotective role of human dental pulp stem cell-conditioned medium in chemotherapy-induced alopecia
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Under Development JAK Inhibitors for Dermatologic Diseases
- Exosome-based cell therapy for diabetic foot ulcers: Present and prospect
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Epidermal homeostasis: a balancing act of stem cells in the skin
- Stem Cell-Derived and Plant-Derived Exosomes: Promising Therapeutics for Skin Healing and Regeneration
- Novel 5α-Reductase Inhibitors: Synthesis, Structure−Activity Studies, and Pharmacokinetic Profile of Phenoxybenzoylphenyl Acetic Acids
- RSPO1-mutated keratinocytes from palmoplantar keratoderma display impaired differentiation, alteration of cell–cell adhesion, EMT-like phenotype and invasiveness properties: implications for squamous cell carcinoma susceptibility in patients with 46XX disorder of sexual development
- Regulation of stem cell fate by HSPGs: implication in hair follicle cycling
- Targeted cell delivery of mesenchymal stem cell therapy for cardiovascular disease applications: a review of preclinical advancements
- Stem Cell Use to Treat Dermatological Disorders
- Challenges and Strategies for Improving the Regenerative Effects of Mesenchymal Stromal Cell-Based Therapies
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Spatial and single-cell transcriptomics unravel the complex interplay between the body and medical implants
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Mesenchymal stem cell‐derived exosomes for organ development and cell‐free therapy
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Animal models for the study of fetal tissue repair